RS59566B1 - Novo jedinjenje i postupak - Google Patents

Novo jedinjenje i postupak

Info

Publication number
RS59566B1
RS59566B1 RS20191474A RSP20191474A RS59566B1 RS 59566 B1 RS59566 B1 RS 59566B1 RS 20191474 A RS20191474 A RS 20191474A RS P20191474 A RSP20191474 A RS P20191474A RS 59566 B1 RS59566 B1 RS 59566B1
Authority
RS
Serbia
Prior art keywords
compound
formula
hydrogen
reaction
carbonate
Prior art date
Application number
RS20191474A
Other languages
English (en)
Serbian (sr)
Inventor
Peter Lionel Spargo
Original Assignee
Verona Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Plc filed Critical Verona Pharma Plc
Publication of RS59566B1 publication Critical patent/RS59566B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
RS20191474A 2016-07-28 2017-07-27 Novo jedinjenje i postupak RS59566B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process
EP17748880.6A EP3490988B1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (1)

Publication Number Publication Date
RS59566B1 true RS59566B1 (sr) 2019-12-31

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20191474A RS59566B1 (sr) 2016-07-28 2017-07-27 Novo jedinjenje i postupak

Country Status (19)

Country Link
US (1) US10710998B2 (https=)
EP (1) EP3490988B1 (https=)
JP (1) JP6985367B2 (https=)
KR (1) KR102396059B1 (https=)
CN (1) CN109641891B (https=)
CY (1) CY1122138T1 (https=)
DK (1) DK3490988T3 (https=)
ES (1) ES2751948T3 (https=)
GB (1) GB201613054D0 (https=)
HR (1) HRP20192109T1 (https=)
HU (1) HUE046509T2 (https=)
LT (1) LT3490988T (https=)
PL (1) PL3490988T3 (https=)
PT (1) PT3490988T (https=)
RS (1) RS59566B1 (https=)
SI (1) SI3490988T1 (https=)
SM (1) SMT201900582T1 (https=)
TW (1) TWI739871B (https=)
WO (1) WO2018020249A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3142701T3 (en) 2014-05-12 2018-08-13 Verona Pharma Plc New treatment
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
PT4090654T (pt) * 2020-01-17 2025-10-07 Lupin Ltd Métodos, processos e intermediários para a preparação de compostos de cromano
CN116917287A (zh) 2021-04-29 2023-10-20 苏州盛迪亚生物医药有限公司 异喹啉酮类化合物及其用途
JP2024545189A (ja) * 2021-12-14 2024-12-05 シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド 三環式縮合複素環系pde3/4二重阻害剤及びその用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
CN121620356A (zh) 2023-06-26 2026-03-06 维罗纳制药公司 包含恩塞芬汀的颗粒组合物
US20250073240A1 (en) 2023-09-06 2025-03-06 Verona Pharma Plc New treatment
US20250249007A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025168708A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1237429A (en) 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
ES2208310T3 (es) 1999-03-31 2004-06-16 Vernalis Limited Derivados de pirimido(6,1-a) isoquinolin-4-ona.
PH12013500261A1 (en) 2010-08-09 2013-03-04 Verona Pharma Plc Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound
EP2968313B1 (en) 2013-03-15 2018-01-31 Verona Pharma PLC Drug combination
DK3142701T3 (en) 2014-05-12 2018-08-13 Verona Pharma Plc New treatment
CN110051627A (zh) 2014-09-15 2019-07-26 维罗纳制药公司 包含rpl554的液体吸入制剂
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Also Published As

Publication number Publication date
SMT201900582T1 (it) 2019-11-13
CY1122138T1 (el) 2020-11-25
JP2019527228A (ja) 2019-09-26
TWI739871B (zh) 2021-09-21
SI3490988T1 (sl) 2019-11-29
KR20190034231A (ko) 2019-04-01
PL3490988T3 (pl) 2020-02-28
EP3490988A1 (en) 2019-06-05
US10710998B2 (en) 2020-07-14
HRP20192109T1 (hr) 2020-02-21
US20190330206A1 (en) 2019-10-31
HUE046509T2 (hu) 2020-03-30
JP6985367B2 (ja) 2021-12-22
DK3490988T3 (da) 2019-10-28
GB201613054D0 (en) 2016-09-14
KR102396059B1 (ko) 2022-05-10
WO2018020249A1 (en) 2018-02-01
EP3490988B1 (en) 2019-08-28
LT3490988T (lt) 2019-10-10
PT3490988T (pt) 2019-10-28
CN109641891A (zh) 2019-04-16
ES2751948T3 (es) 2020-04-02
TW201806951A (zh) 2018-03-01
CN109641891B (zh) 2021-05-04

Similar Documents

Publication Publication Date Title
RS59566B1 (sr) Novo jedinjenje i postupak
CA3039090C (en) Process for preparing btk inhibitors
CN102448942A (zh) 艾曲波帕和艾曲波帕盐的多晶型物及其制备方法
WO2014093579A2 (en) Crystalline forms of 3-(imidazo[1,2-b] pyridazin-3-ylethynyl)-4-methyl-n-(4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl)benzamide and its mono hydrochloride salt
WO2017025981A1 (en) Process for the preparation of methyl 4,6-diamino-2-[l-(2-fhiorobenzvr)-lh-pyrazolo i3,4-blpvridin-3-vn-5-pyrimidinyl(methvl)carbamate and its polymorphs thereof
IL291221B1 (en) Methods for the synthesis of wolbenzen
US12528771B2 (en) Method for producing centanafadine
AU2014389984A1 (en) Process of preparing a quinazoline derivative
TW201625632A (zh) Pi3k抑制劑及其鹽之合成
HK40002783A (en) New compound and process
HK40002783B (en) New compound and process
JP7320113B2 (ja) ヘテロシクリデンアセトアミド誘導体の製造方法
WO2019064222A1 (en) CRYSTALLINE FORMS OF LENALIDOMIDE
GB2317888A (en) Acridone derivatives and preparation of 8-hydroxy-imidazoacridinone derivatives
CN110872270A (zh) 一种环己烷衍生物的盐
WO2026061642A1 (en) Solid form of methyl 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate or a salt thereof, method for the preparation thereof, and use thereof in the synthesis of deucravacitinib
Xia et al. A convenient synthesis of N, N, N'-trisubstituted ethylenediamine derivatives from 2-methyl-2-imidazoline
CN116406365A (zh) 用于制备1-甲基-6-[6-R2-5-甲基-8-(甲基氨基)-4-[(3aS,6aS)-5-甲基-2,3,3a,4,6,6a-六氢吡咯并[2,3-c]吡咯-1-基]-9H-吡啶并[2,3-b]吲哚-3-基]-4-氧代-1,8-萘啶-3-甲酸盐酸盐的方法
KR20260049231A (ko) 아비박탐 및 이의 중간체를 제조하기 위한 개선된 방법
JP2024525477A (ja) 4-アミノ-n-(1-((3-クロロ-2-フルオロフェニル)アミノ)-6-メチルイソキノリン-5-イル)チエノ[3,2-d]ピリミジン-7-カルボキサミドのビス-メシレート塩及びその中間体の合成
WO2023230236A1 (en) Process for preparing jak inhibitors and intermediates thereof
HK40090878A (zh) 用於制备1-甲基-6-[6-r2-5-甲基-8-(甲基氨基)-4-[(3as,6as)-5-甲基-2,3,3a,4,6,6a-六氢吡咯并[2,3-c]吡咯-1-基]-9h-吡啶并[2,3-b]吲哚-3-基]-4-氧代-1,8-萘啶-3-甲酸盐酸盐的方法
HK40108339A (zh) 用於合成缬苯那嗪的方法
HK40031447B (en) Method for preparing sulfonamides drugs
HK40031447A (en) Method for preparing sulfonamides drugs